BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26906088)

  • 1. Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera.
    Cavazzana I; Fredi M; Ceribelli A; Mordenti C; Ferrari F; Carabellese N; Tincani A; Satoh M; Franceschini F
    J Immunol Methods; 2016 Jun; 433():1-5. PubMed ID: 26906088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations.
    Fredi M; Cavazzana I; Ceribelli A; Cavagna L; Barsotti S; Bartoloni E; Benucci M; De Stefano L; Doria A; Emmi G; Fabris M; Fornaro M; Furini F; Giudizi MG; Govoni M; Ghirardello A; Iaccarino L; Iannone F; Infantino M; Isailovic N; Lazzaroni MG; Manfredi M; Mathieu A; Marasco E; Migliorini P; Montecucco C; Palterer B; Parronchi P; Piga M; Pratesi F; Riccieri V; Selmi C; Tampoia M; Tripoli A; Zanframundo G; Radice A; Gerli R; Franceschini F;
    Clin Rev Allergy Immunol; 2022 Oct; 63(2):240-250. PubMed ID: 35092577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
    Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
    Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of myositis-specific autoantibodies on long-term prognosis of juvenile idiopathic inflammatory myopathies: multicentre study.
    Yamasaki Y; Kobayashi N; Akioka S; Yamazaki K; Takezaki S; Nakaseko H; Ohara A; Nishimura K; Nishida Y; Sato S; Kishi T; Hashimoto M; Mori M; Okazaki Y; Kuwana M; Ohta A
    Rheumatology (Oxford); 2021 Oct; 60(10):4821-4831. PubMed ID: 33576399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.
    Merlo G; Clapasson A; Cozzani E; Sanna L; Pesce G; Bagnasco M; Burlando M; Parodi A
    Arch Dermatol Res; 2017 Mar; 309(2):87-95. PubMed ID: 27928683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies.
    Cavazzana I; Richards M; Bentow C; Seaman A; Fredi M; Giudizi MG; Palterer B; Pratesi F; Migliorini P; Franceschini F; Satoh M; Ceribelli A; Mahler M
    J Immunol Methods; 2019 Nov; 474():112661. PubMed ID: 31442464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of ELISA is comparable to immunoprecipitation in the detection of selected myositis-specific autoantibodies in a European population.
    Loganathan A; McMorrow F; Lu H; Li D; Mulhearn B; McHugh NJ; Tansley SL
    Front Immunol; 2022; 13():975939. PubMed ID: 36177007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohort.
    Loganathan A; Gupta L; Rudge A; Lu H; Bowler E; McMorrow F; Naveen R; Anuja AK; Agarwal V; McHugh N; Tansley S
    Rheumatology (Oxford); 2024 Mar; ():. PubMed ID: 38479813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies.
    Hamaguchi Y; Kuwana M; Takehara K
    Clin Rheumatol; 2020 Nov; 39(11):3489-3497. PubMed ID: 32385758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies.
    Mahler M; Betteridge Z; Bentow C; Richards M; Seaman A; Chinoy H; McHugh N
    Front Immunol; 2019; 10():848. PubMed ID: 31114570
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P; Dwivedi S; Misra R
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity.
    Tansley SL; Li D; Betteridge ZE; McHugh NJ
    Rheumatology (Oxford); 2020 Aug; 59(8):2109-2114. PubMed ID: 32030410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcinosis and malignancy are rare in Chinese adult patients with myositis and nuclear matrix protein 2 antibodies identified by an unlabeled immunoprecipitation assay.
    Wang L; Huang L; Yang Y; Chen H; Liu Y; Liu K; Liu M; Xiao Y; Luo H; Zuo X; Li Y; Xiao X; Zhang H
    Clin Rheumatol; 2018 Oct; 37(10):2731-2739. PubMed ID: 30039266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
    Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
    Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An effective algorithm for the serological diagnosis of idiopathic inflammatory myopathies: The key role of anti-Ro52 antibodies.
    Infantino M; Manfredi M; Grossi V; Benucci M; Morozzi G; Tonutti E; Tampoia M; Bizzaro N
    Clin Chim Acta; 2017 Dec; 475():15-19. PubMed ID: 28986052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease.
    Mammen AL; Casciola-Rosen L; Christopher-Stine L; Lloyd TE; Wagner KR
    Neurol Neuroimmunol Neuroinflamm; 2015 Dec; 2(6):e172. PubMed ID: 26668818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myositis-specific autoantibodies in Japanese patients with juvenile idiopathic inflammatory myopathies.
    Ueki M; Kobayashi I; Takezaki S; Tozawa Y; Okura Y; Yamada M; Kuwana M; Ariga T
    Mod Rheumatol; 2019 Mar; 29(2):351-356. PubMed ID: 29532710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort.
    Tarricone E; Ghirardello A; Rampudda M; Bassi N; Punzi L; Doria A
    J Immunol Methods; 2012 Oct; 384(1-2):128-34. PubMed ID: 22884621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank.
    Loganathan A; Zanframundo G; Yoshida A; Faghihi-Kashani S; Bauer Ventura I; Dourado E; Bozan F; Sambataro G; Yamano Y; Bae SS; Lim D; Ceribelli A; Isailovic N; Selmi C; Fertig N; Bravi E; Kaneko Y; Saraiva AP; Jovani V; Bachiller-Corral J; Cifrian J; Mera-Varela A; Moghadam-Kia S; Wolff V; Campagne J; Meyer A; Giannini M; Triantafyllias K; Knitza J; Gupta L; Molad Y; Iannone F; Cavazzana I; Piga M; De Luca G; Tansley S; Bozzalla-Cassione E; Bonella F; Corte TJ; Doyle TJ; Fiorentino D; Gonzalez-Gay MA; Hudson M; Kuwana M; Lundberg IE; Mammen AL; McHugh NJ; Miller FW; Montecucco C; Oddis CV; Rojas-Serrano J; Schmidt J; Scirè CA; Selva-O'Callaghan A; Werth VP; Alpini C; Bozzini S; Cavagna L; Aggarwal R;
    Clin Exp Rheumatol; 2024 Feb; 42(2):277-287. PubMed ID: 38488094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.